These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3582493)

  • 1. Pharmacology of L-655,240 (3-[1-(4-chlorobenzyl)-5-fluoro-3-methyl-indol-2-yl]2,2-dimethylpro pan oic acid); a potent, selective thromboxane/prostaglandin endoperoxide antagonist.
    Hall RA; Gillard J; Guindon Y; Letts G; Champion E; Ethier D; Evans J; Ford-Hutchinson AW; Fortin R; Jones TR
    Eur J Pharmacol; 1987 Mar; 135(2):193-201. PubMed ID: 3582493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-641,953 (R-8-fluoro-dibenzo[b, f]thiepin-3-carboxylic acid-5-oxide): a novel thromboxane-prostaglandin endoperoxide antagonist.
    Hall RA; Rokach JR; Bélanger P; Bianchi L; Ethier D; Ford-Hutchinson AW; Girard Y; Hamel P; Hamel R; Lord A
    Can J Physiol Pharmacol; 1987 Apr; 65(4):509-14. PubMed ID: 3607600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist.
    Ford-Hutchinson AW; Girard Y; Lord A; Jones TR; Cirino M; Evans JF; Gillard J; Hamel P; Leveillé C; Masson P
    Can J Physiol Pharmacol; 1989 Sep; 67(9):989-93. PubMed ID: 2598135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist.
    Jones TR; Young R; Champion E; Charette L; Denis D; Ford-Hutchinson AW; Frenette R; Gauthier JY; Guindon Y; Kakushima M
    Can J Physiol Pharmacol; 1986 Aug; 64(8):1068-75. PubMed ID: 3024787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
    Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN
    J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.
    Ogletree ML; Harris DN; Greenberg R; Haslanger MF; Nakane M
    J Pharmacol Exp Ther; 1985 Aug; 234(2):435-41. PubMed ID: 3926986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
    Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA
    J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the antagonist profile of SK&F 88046 on guinea pig trachea.
    Weichman BM; DeVan JF; Muccitelli RM; Tucker SS; Vickery LM; Wasserman MA
    Prostaglandins Leukot Med; 1984 Aug; 15(2):167-75. PubMed ID: 6593742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological actions of ICI 180080, a novel thromboxane receptor antagonist.
    Jessup CL; Jessup R; Wayne M
    J Pharm Pharmacol; 1986 Oct; 38(10):754-7. PubMed ID: 2878996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.
    Huzoor-Akbar ; Mukhopadhyay A; Anderson KS; Navran SS; Romstedt K; Miller DD; Feller DR
    Biochem Pharmacol; 1985 Mar; 34(5):641-7. PubMed ID: 3156599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G; Smith GM
    Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.
    Jones TR; Labelle M; Belley M; Champion E; Charette L; Evans J; Ford-Hutchinson AW; Gauthier JY; Lord A; Masson P
    Can J Physiol Pharmacol; 1995 Feb; 73(2):191-201. PubMed ID: 7621356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist.
    Perzborn E; Fiedler VB; Seuter F; Stasch JP; Weber H; Sander E; Böshagen H; Rosentreter U
    Stroke; 1990 Dec; 21(12 Suppl):IV143-5. PubMed ID: 2148034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of prostanoid-mediated platelet aggregation in vivo and in vitro by 3-hydroxymethyl-dibenzo(b,f)thiepin 5,5-dioxide (L-640,035).
    Chan CC; Nathaniel DJ; Yusko PJ; Hall RA; Ford-Hutchinson AW
    J Pharmacol Exp Ther; 1984 Apr; 229(1):276-82. PubMed ID: 6423813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on L-640,035: a novel antagonist of contractile prostanoids in the lung.
    Carrier R; Cragoe EJ; Ethier D; Ford-Hutchinson AW; Girard Y; Hall RA; Hamel P; Rokach J; Share NN; Stone CA
    Br J Pharmacol; 1984 Jun; 82(2):389-95. PubMed ID: 6428502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.